CCL5 promotes anti-tumor immunity by recruiting anti-tumor T cells and dendritic cells to the tumor microenvironment, and, in this way, it increases the immunotherapy response in different tumor types, as reviewed in [24]. Here, CCL5 is linked to neoplasm.